Ben Fountain
AUTHOR

Ben Fountain

Tap the gear icon above to manage new release emails.
Ben Fountain's novel BILLY LYNN'S LONG HALFTIME WALK received the National Book Critics' Circle Award, the Los Angeles Times Book Award, the Flaherty-Dunnan First Novel Award, the PEN/New England Cerulli Award for Excellence in Sports Writing, and the Jesse Jones Award for fiction from the Texas Institute of Letters, and was a finalist for the National Book Award in both the US and the UK (international authors division). The film adaptation of BILLY LYNN, directed by three-time Oscar winner Ang Lee, was released in 2016 by Sony Pictures. Fountain's short story collection BRIEF ENCOUNTERS WITH CHE GUEVARA received the PEN/Hemingway Award, the Barnes & Noble Discover Award for Fiction, and a Whiting Writers Award. Fountain's short fiction has appeared in Harper's, Zoetrope: All-Story, the Paris Review, Esquire, the Sewanee Review, DALLAS NOIR, and HAITI NOIR II, among other publications. His nonfiction has appeared in the New York Times, the New York Times Magazine, the Guardian, the Wall Street Journal, Le Monde, Texas Monthly, and elsewhere, and his reportage on post-earthquake Haiti was broadcast on the radio show This American Life. Fountain grew up in the tobacco country of eastern North Carolina, and is a graduate of UNC-Chapel Hill and Duke University Law School. A former attorney in private practice, he has lived in Dallas, Texas for over thirty years. In September, 2018, Ecco/HarperCollins will publish Fountain's nonfiction book BEAUTIFUL COUNTRY BURN AGAIN, which is based on his reportage for the Guardian of the US presidential campaign of 2016.
Read more Read less

Best Sellers

Product List
  • Beautiful Country Burn Again cover art

    ₹2,337.00 or free with 30-day trial

    Free with 30-day trial
  • Billy Lynn's Long Halftime Walk cover art

    ₹2,045.00 or free with 30-day trial

    Free with 30-day trial
  • Brief Encounters with Che Guevara cover art

    ₹1,826.00 or free with 30-day trial

    Free with 30-day trial